– Bloomberg
EF Hutton Maintains Buy on Nanoviricides, Lowers Price Target to $5.25
EF Hutton analyst Constantine Davides maintains Nanoviricides (AMEX:NNVC) with a Buy and lowers the price target from $8.5 to $5.25.
Related Posts
These Analysts Revise Their Forecasts On Restaurant Brands After Q3 Results
Restaurant Brands International Inc (NYSE: QSR) reported weaker-than-expected third-quarter sales on Friday.
Keefe, Bruyette & Woods Maintains Outperform on Cadence Bank, Lowers Price Target to $32
Keefe, Bruyette & Woods analyst Catherine Mealor maintains Cadence Bank (NYSE:CADE) with a Outperform and lowers the price target from $35 to $32.
Mizuho Maintains Buy on Apartment Income REIT, Lowers Price Target to $40
Mizuho analyst Haendel St. Juste maintains Apartment Income REIT (NYSE:AIRC) with a Buy and lowers the price target from $46 to $40.